Cardiac Marker Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cardiac Marker Tests Market Report Overview
The Cardiac Marker Tests market size was valued at $1.48 billion in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Cardiac Marker testing is used to determine the fall and rise of levels of specific cardiac markers such as troponin, brain natriuretic peptide (BNP), or creatine kinase – myocardial band (CK-MB) in suspected and/or existing ACS and HF patients.
Cardiac Marker Tests Market Outlook, 2023-2033 ($ Billion)
Buy Full Report for More Insights into the Cardiac Marker Tests Market Forecast
The Cardiac Marker Tests market research report has been created to understand market behavior, which will help identify quantitative market trends in the In Vitro therapeutic area. It discusses in detail the impact of COVID-19 on the cardiac marker tests market for the year 2020 and beyond.
Market Size (2023) | $1.48 Billion |
CAGR (2023-2033) | >1% |
Forecast Period | 2024-2033 |
Historical Period | 2015-2023 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Troponin Laboratory Tests
· Brain Natriuretic Peptide (BNP) Laboratory Tests · Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests · Creatine Kinase – Myocardial Band (CK-MB) Laboratory Tests · Other Cardiac Marker Point of Care (POC) Tests · Troponin Point of Care (POC) Tests |
Leading Companies | · F. Hoffmann-La Roche Ltd
· Abbott Laboratories · Quidel Corp · Beckman Coulter Inc+Radiometer Medical ApS · Siemens Healthineers AG · bioMerieux SA |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Cardiac Marker Tests Market Dynamics
The rise in the use of combined troponin and creatine kinase myocardial band (CK-MB) testing is a critical driver of the Cardiac Marker Tests market growth. The testing procedure is used to re-classify many patients previously diagnosed as having UA to non-ST-segment elevation myocardial infarction (NSTEMI). In addition, the release of accredited guidelines for the management of ACS and HF is also expected to shape the market growth in the coming years.
Cardiac Marker Tests Market Segmentation by Regions
The key regions in the Cardiac Marker Tests market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America dominated the overall Cardiac Marker Test market in 2023 and is expected to continue to lead over the forecast years. The growth will be attributed to the rising cases of diabetes and obesity and the presence of a huge population of elderly individuals demanding an earlier diagnosis for better treatment.
Cardiac Marker Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Insights into the Regions in Cardiac Marker Tests Market
Cardiac Marker Tests Market Segments
The key segments in the Cardiac Marker Tests market are Brain Natriuretic Peptide (BNP) Laboratory Tests, Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests, Creatine Kinase – Myocardial Band (CK-MB) Laboratory Tests, Other Cardiac Marker Point of Care (POC) Tests, Troponin Laboratory Tests, and Troponin Point of Care (POC) Tests. Troponin Laboratory Tests led the market in 2023.
Troponin Laboratory Tests are carried out to measure Troponin. It is a regulatory protein that is uniquely present on striated muscle, which regulates the calcium-mediated interaction of actin and myosin. Cardiac troponins have additional amino acid residues on the N-terminal region of the protein, which is not present in the skeletal forms making them a promising analyte protein for indicating cardiac specificity.
Cardiac Marker Tests Market Analysis, by Segments 2023 (%)
Buy the Full Report For More Insights into the Segments in Cardiac Marker Tests Market
Cardiac Marker Tests Market - Competitive Landscape
A few of the leading companies in the Cardiac Marker Tests market are:
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Quidel Corp
- Beckman Coulter Inc+Radiometer Medical ApS
- Siemens Healthineers AG
- bioMerieux SA
Hoffmann-La Roche Ltd dominated the market in 2023. It is followed by Abbott Laboratories.
Cardiac Marker Tests Market Analysis, by Companies 2023 (%)
Buy the Full Report For More Insights into the Companies in Cardiac Marker Tests Market
Segments Covered in the Report
Cardiac Marker Tests Segments Outlook (Value, $ Billion, 2015-2033)
- Troponin Laboratory Tests
- Brain Natriuretic Peptide (BNP) Laboratory Tests
- Brain Natriuretic Peptide (BNP) Point of Care (POC) Tests
- Creatine Kinase – Myocardial Band (CK-MB) Laboratory Tests
- Other Cardiac Marker Point of Care (POC) Tests
- Troponin Point of Care (POC) Tests
Cardiac Marker Tests Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed Cardiac Marker and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Cardiac Marker market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Cardiac Marker market.
- Competitive dynamics insights and trends provided for the Cardiac Marker market.
Drive the understanding of the market by getting the veritable big picture, including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Quidelortho Corp, F. Hoffmann-La Roche Ltd, Siemens AG, bioMerieux SA, Danaher Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Cardiac Marker Tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Cardiac Marker Tests market.
- Competitive dynamics insights and trends provided for the Cardiac Marker Tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on the Cardiac Marker Tests market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Cardiac Marker Tests market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cardiac Marker Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Cardiac Marker Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Quidelortho Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Siemens AG
bioMerieux SA
Others
Frequently asked questions
-
What was the Cardiac Marker Tests market size in 2023?
The Cardiac Marker Tests market size was $1.48 billion in 2023.
-
What will be the Cardiac Marker Tests market growth rate in the forecast period?
The Cardiac Marker Tests market is expected to grow at a CAGR of more than 1% during 2023-2033.
-
Which region dominated the Cardiac Marker Tests market in 2023?
North America dominated the overall Cardiac Marker Test market in 2023.
-
Which segment led the Cardiac Marker market in 2023?
The Troponin Laboratory Tests segment led the market in 2023.
-
Which are the leading companies in the Cardiac Marker market?
A few of the leading companies in the Cardiac Marker Test market are Abbott Laboratories, Quidel Corp, Beckman Coulter Inc+Radiometer Medical ApS, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, and bioMerieux SA.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.